Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are up 8% in Tuesday’s trading session, after the drug maker announced that the International Rett Syndrome …
Anavex Life Sciences Corp. (NASDAQ:AVXL) and the International Rett Syndrome Foundation, doing business as Rettsyndrome.
Anavex Life Sciences Corp. (NASDAQ:AVXL) shareholders woke up to a nice 8% pop in the value of their shares, after the drug maker announced …
Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are on a 10% rise after biotech firm Lilly’s drug Solanezumab (“Sola”) just failed its third Phase …
Anavex Life Sciences Corp. (NASDAQ:AVXL) investors have a smile on their faces Tuesday, after the drug maker announced a positive 41-week update from its …
Anavex Life Sciences Corp. (NASDAQ:AVXL) announced that its oral pipeline drug candidate 2-73, developed to potentially modify Alzheimer’s disease rather than just temporarily …
Anavex Life Sciences Corp. (NASDAQ:AVXL) announced a collaboration with Ariana Pharma (Cambridge, MA and Paris, France) to use Ariana’s proprietary KEM® (Knowledge, Extraction, …
In a research report released Thursday, FBR Capital analyst Christopher James reiterated an Outperform rating on shares of Anavex Life Sciences Corp. (NASDAQ:AVXL), …
Anavex Life Sciences Corp. (NASDAQ:AVXL) investors are cheering the news that the company has signed a material transfer agreement with Biogen (Cambridge, MA) under …
Yesterday morning, Anavex Life Sciences Corp (NASDAQ:AVXL) presented positive data after investigating its pipeline drug Anavex 2073, a sigma-1 receptor antagonist that could …
